Efficacy of Esketamine for Patients With Irritable Bowel Syndrome | MicrobiomeTrials← Back to trialsNCT06788444
Efficacy of Esketamine for Patients With Irritable Bowel Syndrome
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-02-08Est. Completion: 2026-12-31
Enrollment target: 552 participants Locations- Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
Other microbiome trials you might be interested in
FibromyalgiaDiet, Gluten-Free
The purpose of this study is to evaluate the efficacy of two diets - gluten-free and low-FODMAP diet- in relieving sympt…
Montreal, CanadaCompleted Jun 15, 2022
ConstipationProbioticProbiotic Intervention
Constipation is a prevalent gastrointestinal condition. Beyond simple lifestyle measures (e.g. increasing fibre intake, …
London, United KingdomCompleted Jul 20, 2026
Recruiting
Irritable Bowel Syndrome (IBS)
Randomized, single-blind, sham-controlled crossover study evaluating the efficacy and safety of transcutaneous auricular…
Multiple LocationsEst. completion Dec 31, 2028